Hair Fairies tutors parents
This article was originally published in The Rose Sheet
Executive Summary
Sensitive to families' tight budgets in a trying economy, Los Angeles-based chain of upscale kid-friendly salons will launch a do-it-yourself lice removal video guide on its Web site Feb. 3. "When a client is treated in-store," Hair Fairies says, "there is a 100% service guarantee. But in the current economic climate, many families are wary of the additional out-of-pocket expense involved in visiting a head lice salon." A written step-by-step tutorial already is available at HairFairies.com, with links to purchase the "all-natural," FDA-approved Hair Fairies products used in the process. A home kit consisting of Nit-Zapping Clenz Shampoo, Clenz Cream and a nit comb costs $45. Company founder Maria Botham appeared on ABC's "Good Morning America" Jan. 26 to discuss Hair Fairies' salon services, calling the company "the Starbucks of head-lice removal." Concerned parents also are invited to call the brand's free Head Lice Hotline. Fairy Tales Hair Care is another company offering head-lice treatments touted as natural, non-toxic alternatives to harsher insecticides on the market (1"The Rose Sheet" May 18, 2009)
You may also be interested in...
Fairy Tales’ Rosemary Repel Line Offers Natural, Effective Lice Prevention
Fairy Tales Hair Care heads into summer camp season with independent, in vitro study results that suggest its all-natural Rosemary Repel line is more than 92 percent effective at preventing lice infestation
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.